*001690798
*00520190107202022.0
*007ta
*008160628s2016    no       m    00  0 eng
*00901475nam a2200325 c 4500
*019  $bl
*020  $a978-82-8333-177-6$qh.
*035  $a(EXLNZ-47BIBSYS_NETWORK)999920134484602201
*035  $a(NO-LaBS)14484377(bibid)
*040  $aNO-OsNB$bnob$ekatreg
*060 4$aQV 21
*08204$a174.2951$223/nor$qNO-OsNB
*1001 $aHole, Ola Peder$d1936-$0(NO-TrBIB)1465453925661$4aut$_97661600
*24510$aClinical development of drugs in Norway :$bethical consideration$cby Ola Peder Hole
*260  $a[Oslo]$bInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo$c2016
*300  $a1b. (flere pag.)$c24 cm
*4901 $aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (dr.philos.) - Universitetet i Oslo, 2016
*650 2$aBiomedical Research$xethics$0D035843Q000941$_97661700
*650 2$aDrug Evaluation$xstatistics & numerical data$0D004341Q000706$_97661800
*650 2$aDrug Industry$0D004345$_97661900
*650 2$aEthics, Research$0D032984$_97662000
*650 2$aPharmacology, Clinical$xethics$0D010601Q000941$_97662100
*7102 $aUniversitetet i Oslo$bDet medisinske fakultet$0(NO-TrBIB)90302138$4pbl$_10213300
*7102 $aUniversitetet i Oslo$bInstitutt for klinisk medisin$0(NO-TrBIB)15000758$4dgg$_10213400
*830 0$aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo (trykt utg.)$_204428900
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:999919843877702202$b2021-11-14T20:42:27Z$z999919843877702202
^